Work

An accelerated pathway for targeted cancer therapies

Year: 2011

Type: article

Source: Nature Reviews Drug Discovery

DOI: 10.1038/nrd3360

Authors: Mark McClellan, Joshua Benner, Richard Schilsky, David Epstein, Ray Woosley, Stephen Friend, David Sidransky, Cindy Geoghegan, David Kessler

Institutions: Brookings Institution, University of Chicago, University of Chicago Medical Center, Novartis (Switzerland), Critical Path Institute, Sage Bionetworks, Johns Hopkins University, University of California, San Francisco

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: SPORE in Head and Neck Cancer, Integrated Development of Novel Molecular Markers

OpenAlex ID: W2025499475

FWCI: 17.03

Cites: 7

Cited by: 32

Related to: 10